Tapewire

NYSE · USD

CYH

COMMUNITY HEALTH SYSTEMS INC

Export transactions ↓
Tapewire entity
5628
SEC CIK
0001108109
Parsed reports
301

Last 12 months

Inside the activity.

0 purchase rows · 1 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202601
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
March 01, 2024 Filed Mar 2, 2024 00:56 UTC
HAMMONS KEVIN JPresident and CFO
Exercise / conversionPerformance Based Restricted · Derivative 120,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024230 · ownership.xml · derivative · entry 4

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,000

Underlying: Common Stock · 120,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these 150,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (120,000), and the remaining 20% of the target number has been forfeited (30,000).

F1 · derivative.expiration_date: The vesting of these 150,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (120,000), and the remaining 20% of the target number has been forfeited (30,000).

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:56 UTC
HAMMONS KEVIN JPresident and CFO
Tax withholdingCommon Stock 78,701 $2.87 $225,871.87
Disclosure

SEC source: 0000950170-24-024230 · ownership.xml · nonDerivative · entry 3

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 564,366

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:56 UTC
HAMMONS KEVIN JPresident and CFO
GrantCommon Stock 90,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024230 · ownership.xml · nonDerivative · entry 2

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 643,067

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:56 UTC
HAMMONS KEVIN JPresident and CFO
Exercise / conversionCommon Stock 120,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024230 · ownership.xml · nonDerivative · entry 1

HAMMONS KEVIN J · CIK 0001542264 · President and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 553,067

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these 150,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (120,000), and the remaining 20% of the target number has been forfeited (30,000).

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MEDLEY MARK BRegional President
GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.87 $0.00
Disclosure

SEC source: 0000950170-24-024228 · ownership.xml · derivative · entry 6

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-02-28

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MEDLEY MARK BRegional President
GrantPerformance Based Restricted · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024228 · ownership.xml · derivative · entry 5

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MEDLEY MARK BRegional President
Exercise / conversionPerformance Based Restricted · Derivative 15,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024228 · ownership.xml · derivative · entry 4

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MEDLEY MARK BRegional President
Tax withholdingCommon Stock 16,197 $2.87 $46,485.39
Disclosure

SEC source: 0000950170-24-024228 · ownership.xml · nonDerivative · entry 3

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,819

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MEDLEY MARK BRegional President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024228 · ownership.xml · nonDerivative · entry 2

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 125,016

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MEDLEY MARK BRegional President
Exercise / conversionCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024228 · ownership.xml · nonDerivative · entry 1

MEDLEY MARK B · CIK 0001863028 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,016

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MASON AUSTEN DRegional President
GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.87 $0.00
Disclosure

SEC source: 0000950170-24-024227 · ownership.xml · derivative · entry 5

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-02-28

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MASON AUSTEN DRegional President
GrantPerformance Based Restricted · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024227 · ownership.xml · derivative · entry 4

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MASON AUSTEN DRegional President
Exercise / conversionPerformance Based Restricted · Derivative 15,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024227 · ownership.xml · derivative · entry 3

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MASON AUSTEN DRegional President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024227 · ownership.xml · nonDerivative · entry 2

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 107,000

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:55 UTC
MASON AUSTEN DRegional President
Exercise / conversionCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024227 · ownership.xml · nonDerivative · entry 1

MASON AUSTEN D · CIK 0001863033 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 82,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
COVA CHARLES JRegional President
GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.87 $0.00
Disclosure

SEC source: 0000950170-24-024225 · ownership.xml · derivative · entry 3

COVA CHARLES J · CIK 0001994357 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 25,000 shares

Expires 2034-02-28

F3 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
COVA CHARLES JRegional President
GrantPerformance Based Restricted · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024225 · ownership.xml · derivative · entry 2

COVA CHARLES J · CIK 0001994357 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F2 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

F2 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
COVA CHARLES JRegional President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024225 · ownership.xml · nonDerivative · entry 1

COVA CHARLES J · CIK 0001994357 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 58,701

F1 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
CAMPBELL CHAD ARegional President
GrantStock Options (Right to Buy) · Derivative 25,000 $0.00 Strike: $2.87 $0.00
Disclosure

SEC source: 0000950170-24-024224 · ownership.xml · derivative · entry 6

CAMPBELL CHAD A · CIK 0001862053 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,000

Underlying: Common Stock · 25,000 shares

Expires 2034-02-28

F4 · derivative.exercise_date: Vesting occurs in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
CAMPBELL CHAD ARegional President
GrantPerformance Based Restricted · Derivative 50,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024224 · ownership.xml · derivative · entry 5

CAMPBELL CHAD A · CIK 0001862053 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 50,000

Underlying: Common Stock · 50,000 shares

Expires not disclosed

F3 · derivative.exercise_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

F3 · derivative.expiration_date: The vesting of these performance-based restricted shares is allocated to the attainment of the following pre-determined performance objectives between 1/1/2024 and 12/31/2026 (the "2024-2026 Performance Period"), as follows: 50% to a Cumulative Consolidated Adjusted EBITDA Growth target; and 50% to a Cumulative Same-Store Net Revenue Growth target. The target number (100%) of the total performance-based restricted shares is reported in the table set forth above. Between 0% and 200% of the portion of the target number of performance-based restricted shares allocated to each performance objective will ultimately vest on the third anniversary of the date of grant, subject to the attainment of the applicable performance objective, with the vesting percentage to be determined based upon the level of achievement with respect to the applicable performance objective during the 2024-2026 Performance Period.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
CAMPBELL CHAD ARegional President
Exercise / conversionPerformance Based Restricted · Derivative 15,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024224 · ownership.xml · derivative · entry 4

CAMPBELL CHAD A · CIK 0001862053 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

F1 · derivative.expiration_date: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
CAMPBELL CHAD ARegional President
Tax withholdingCommon Stock 14,431 $2.87 $41,416.97
Disclosure

SEC source: 0000950170-24-024224 · ownership.xml · nonDerivative · entry 3

CAMPBELL CHAD A · CIK 0001862053 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 115,287

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
CAMPBELL CHAD ARegional President
GrantCommon Stock 25,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024224 · ownership.xml · nonDerivative · entry 2

CAMPBELL CHAD A · CIK 0001862053 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 129,718

F2 · shares: The time-vesting restrictions on this award of restricted stock will lapse in 1/3 increments on the first, second and third anniversary of the date of grant.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:54 UTC
CAMPBELL CHAD ARegional President
Exercise / conversionCommon Stock 15,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024224 · ownership.xml · nonDerivative · entry 1

CAMPBELL CHAD A · CIK 0001862053 · Regional President

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 104,718

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 100% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:53 UTC GrantRestricted Stock Units · Derivative 62,718 $2.87 Strike: $0.00 $180,000.66
Disclosure

SEC source: 0000950170-24-024223 · ownership.xml · derivative · entry 5

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,718

Underlying: Common Stock · 62,718 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:53 UTC Exercise / conversionRestricted Stock Units · Derivative 9,756 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024223 · ownership.xml · derivative · entry 4

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,512

Underlying: Common Stock · 9,756 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:53 UTC Exercise / conversionRestricted Stock Units · Derivative 5,894 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024223 · ownership.xml · derivative · entry 3

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,894

Underlying: Common Stock · 5,894 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:53 UTC Exercise / conversionCommon Stock 9,756 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024223 · ownership.xml · nonDerivative · entry 2

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 124,712

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:53 UTC Exercise / conversionCommon Stock 5,894 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024223 · ownership.xml · nonDerivative · entry 1

Williams Hubert James · CIK 0001659816 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 114,956

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:52 UTC GrantRestricted Stock Units · Derivative 92,334 $2.87 Strike: $0.00 $264,998.58
Disclosure

SEC source: 0000950170-24-024222 · ownership.xml · derivative · entry 7

SMITH WAYNE T · CIK 0001018660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,334

Underlying: Common Stock · 92,334 shares

Expires not disclosed

F3 · derivative.exercise_date: The restricted stock units, which were granted as payment of the Reporting Person's additional annual stipend for serving as the Chair of the Board, vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

F3 · derivative.expiration_date: The restricted stock units, which were granted as payment of the Reporting Person's additional annual stipend for serving as the Chair of the Board, vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:52 UTC GrantRestricted Stock Units · Derivative 62,718 $2.87 Strike: $0.00 $180,000.66
Disclosure

SEC source: 0000950170-24-024222 · ownership.xml · derivative · entry 6

SMITH WAYNE T · CIK 0001018660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,718

Underlying: Common Stock · 62,718 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:52 UTC Disposition to issuerPerformance Based Restricted · Derivative 36,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024222 · ownership.xml · derivative · entry 5

SMITH WAYNE T · CIK 0001018660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 36,000 shares

Expires not disclosed

F1 · derivative.exercise_date: The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (144,000), and the remaining 20% of the target number has been forfeited (36,000).

F1 · derivative.expiration_date: The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (144,000), and the remaining 20% of the target number has been forfeited (36,000).

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:52 UTC Exercise / conversionPerformance Based Restricted · Derivative 144,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024222 · ownership.xml · derivative · entry 4

SMITH WAYNE T · CIK 0001018660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,000

Underlying: Common Stock · 144,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (144,000), and the remaining 20% of the target number has been forfeited (36,000).

F1 · derivative.expiration_date: The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (144,000), and the remaining 20% of the target number has been forfeited (36,000).

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:52 UTC Exercise / conversionCommon Stock 144,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024222 · ownership.xml · nonDerivative · entry 1

SMITH WAYNE T · CIK 0001018660 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,227,075

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: The vesting of these 180,000 performance-based restricted shares was based on the attainment of certain performance objectives between 1/1/2021 and 12/31/2023 (the "2021-2023 Performance Period"). Based on the actual level of achievement of such performance objectives for the 2021-2023 Performance Period, the award vested on March 1, 2024 at 80% of the target number of the performance-based restricted shares originally reported by the Reporting Person on 3/2/2021 (144,000), and the remaining 20% of the target number has been forfeited (36,000).

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:52 UTC GrantRestricted Stock Units · Derivative 62,718 $2.87 Strike: $0.00 $180,000.66
Disclosure

SEC source: 0000950170-24-024220 · ownership.xml · derivative · entry 2

Krishnan K Ranga · CIK 0001724829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,718

Underlying: Common Stock · 62,718 shares

Expires not disclosed

F1 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

F1 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC GrantRestricted Stock Units · Derivative 62,718 $2.87 Strike: $0.00 $180,000.66
Disclosure

SEC source: 0000950170-24-024219 · ownership.xml · derivative · entry 2

JENNINGS WILLIAM NORRIS · CIK 0001435225 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,718

Underlying: Common Stock · 62,718 shares

Expires not disclosed

F1 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

F1 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC GrantRestricted Stock Units · Derivative 62,718 $2.87 Strike: $0.00 $180,000.66
Disclosure

SEC source: 0000950170-24-024217 · ownership.xml · derivative · entry 7

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,718

Underlying: Common Stock · 62,718 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC Exercise / conversionRestricted Stock Units · Derivative 9,756 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024217 · ownership.xml · derivative · entry 6

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,512

Underlying: Common Stock · 9,756 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC Exercise / conversionRestricted Stock Units · Derivative 5,894 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024217 · ownership.xml · derivative · entry 5

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,894

Underlying: Common Stock · 5,894 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC Exercise / conversionRestricted Stock Units · Derivative 6,432 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024217 · ownership.xml · derivative · entry 4

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,432 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC Exercise / conversionCommon Stock 9,756 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024217 · ownership.xml · nonDerivative · entry 3

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 74,908

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC Exercise / conversionCommon Stock 5,894 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024217 · ownership.xml · nonDerivative · entry 2

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 65,152

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:51 UTC Exercise / conversionCommon Stock 6,432 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024217 · ownership.xml · nonDerivative · entry 1

Hirsch Elizabeth T · CIK 0001508503 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 59,258

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:50 UTC GrantRestricted Stock Units · Derivative 62,718 $2.87 Strike: $0.00 $180,000.66
Disclosure

SEC source: 0000950170-24-024216 · ownership.xml · derivative · entry 3

Hastings Joseph Arthur · CIK 0001658614 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,718

Underlying: Common Stock · 62,718 shares

Expires not disclosed

F1 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

F1 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary of the date of grant. Based on the Reporting Person's prior deferral election pursuant to the terms of the award agreement, the Reporting Person will be issued that number of shares of common stock of the Company upon the Reporting Person's cessation as a director or upon a date specified by the Reporting Person.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:50 UTC
FRY JOHN ADirector
GrantRestricted Stock Units · Derivative 62,718 $2.87 Strike: $0.00 $180,000.66
Disclosure

SEC source: 0000950170-24-024214 · ownership.xml · derivative · entry 7

FRY JOHN A · CIK 0001255140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,718

Underlying: Common Stock · 62,718 shares

Expires not disclosed

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:50 UTC
FRY JOHN ADirector
Exercise / conversionRestricted Stock Units · Derivative 9,756 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024214 · ownership.xml · derivative · entry 6

FRY JOHN A · CIK 0001255140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 19,512

Underlying: Common Stock · 9,756 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:50 UTC
FRY JOHN ADirector
Exercise / conversionRestricted Stock Units · Derivative 5,894 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024214 · ownership.xml · derivative · entry 5

FRY JOHN A · CIK 0001255140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,894

Underlying: Common Stock · 5,894 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:50 UTC
FRY JOHN ADirector
Exercise / conversionRestricted Stock Units · Derivative 6,432 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024214 · ownership.xml · derivative · entry 4

FRY JOHN A · CIK 0001255140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 6,432 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

F2 · derivative.expiration_date: The restricted stock units vest in 1/3 increments on the first, second and third anniversary date of the date of the grant. Upon vesting, the Reporting Person will be issued that number of shares of common stock of the Company.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:50 UTC
FRY JOHN ADirector
Exercise / conversionCommon Stock 9,756 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024214 · ownership.xml · nonDerivative · entry 3

FRY JOHN A · CIK 0001255140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 181,815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document
March 01, 2024 Filed Mar 2, 2024 00:50 UTC
FRY JOHN ADirector
Exercise / conversionCommon Stock 5,894 $0.00 $0.00
Disclosure

SEC source: 0000950170-24-024214 · ownership.xml · nonDerivative · entry 2

FRY JOHN A · CIK 0001255140 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 172,059

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · price: The security converts to common stock on a one-to-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.